Christian Garcia
TETRA TECHNOLOGIESAbout Christian A. Garcia
Independent director (age 61) with 30+ years of finance leadership across energy services, industrials, and automotive electronics; designated Audit Committee Financial Expert. Joined TETRA’s board in May 2023; serves on the Audit Committee and the Nominating, Governance & Sustainability Committee, and will become Audit Committee Chair immediately after the 2025 Annual Meeting . Education: B.S., University of the Philippines; Master’s in Business, Purdue University .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| BrandSafway | EVP & Chief Financial Officer | Oct 2020 – May 2023 | Led finance for industrial services company |
| Weatherford International (WFRD) | EVP & Chief Financial Officer | Jan 2020 – Aug 2020 | Oversaw finance at oilfield services firm |
| Visteon (VC) | EVP & Chief Financial Officer | 2016 – Oct 2019 | CFO for automotive electronics supplier |
| Halliburton (HAL) | Acting CFO; CAO; Treasurer; SVP IR (prior roles) | Not specified | Senior finance leadership and capital markets roles |
| Self-employed | Independent period | Oct 2019 – Jan 2020; Aug 2020 – Oct 2020 | Transition/consulting periods |
External Roles
| Company | Exchange/Ticker | Role | Status |
|---|---|---|---|
| Dana Inc. | NYSE: DAN | Director | Current |
| Bausch Health Companies Inc. | NYSE: BHC | Director | Current |
| Mueller Water Products, Inc. | NYSE: MWA | Director | Current |
| Keane Group, Inc. | NYSE: FRAC | Director | Former |
Board Governance
- Committee assignments (TTI): Audit; Nominating, Governance & Sustainability (NGSC) . Audit Committee Chair-designate (effective after 2025 Annual Meeting) . Audit Committee Financial Expert .
- Independence: Board determined Garcia is independent under NYSE rules .
- Attendance: In 2024, the Board met 7 times; Audit 5; NGSC 5. Each director attended ≥75% of Board and committee meetings of which they were a member .
- Board structure and practices: Independent Chair separate from CEO; regular executive sessions of independent directors; robust ERM and cybersecurity oversight; director resignation (“plurality plus”) policy .
Fixed Compensation (Director)
| Component | Amount/Description | Source |
|---|---|---|
| 2024 Cash Fees (Garcia) | $90,000 | |
| 2024 Equity Grant (RSUs) (Garcia) | $108,063 grant-date fair value; 26,551 RSUs vesting on 1-year anniversary | |
| Total 2024 Director Comp (Garcia) | $198,063 | |
| Standard Non‑Employee Director Retainer | $90,000 cash; $110,000 equity (RSUs, 1-year vest) | |
| Committee Chair Retainers | Audit $20,000; HCMCC $15,000; NGSC $15,000 (cash) |
Notes:
- Majority of director pay delivered in equity per Board policy .
- Directors may defer cash and RSU settlement under TTI deferred compensation plans .
Performance Compensation
- Not applicable to directors. Annual director equity awards are time‑based RSUs with 1‑year vest; no performance metrics or options used for director pay .
Other Directorships & Interlocks
| Category | Details |
|---|---|
| Current public boards | Dana (DAN); Bausch Health (BHC); Mueller Water Products (MWA) |
| Potential interlocks with TTI stakeholders | None disclosed in “Certain Transactions” or independence reviews; Board affirmed independence following related party review |
Expertise & Qualifications
- Finance/accounting/capital markets; public company CFO across multiple sectors; global operations experience; Audit Committee Financial Expert .
- Energy and industrials domain exposure (Halliburton, Weatherford, BrandSafway) .
Equity Ownership
| Item | Value | Source |
|---|---|---|
| Beneficial ownership (Garcia) | 65,642 shares (includes 26,551 RSUs vesting within 60 days) | |
| Unvested RSUs outstanding (12/31/24) | 26,551 RSUs for each non‑employee director (including Garcia), unvested at year‑end | |
| Shares outstanding (record date) | 133,071,751 (as of Apr 23, 2025) | |
| Ownership as % of outstanding | ~0.049% (= 65,642 / 133,071,751) | |
| Director ownership guideline | 5x annual cash retainer; 4 years to comply; as of proxy date, all non‑employee directors are in compliance subject to transition periods |
Pledging/hedging: TTI policy prohibits short sales, certain derivatives/hedging; pledging only by exception with pre‑approval; no hedging transactions approved .
Governance Assessment
Strengths
- Deep finance leadership and designated Audit Committee Financial Expert; slated to chair Audit—supports financial reporting, controls, and risk oversight .
- Independent director; Board maintains separated Chair/CEO and strong governance practices (plurality‑plus, stock ownership guidelines, clawback for executives) .
- Attendance threshold met (≥75%); clear committee engagement; robust stockholder engagement and 2024 say‑on‑pay approval >92% indicating investor alignment context .
Watch items
- Board workload: concurrently serves on three other public company boards; as incoming Audit Chair at TTI, monitor time commitments and attendance given Audit Committee demands .
- Related-party/pledging risk: none disclosed; continue to monitor compliance with trading and pledging policy .
Potential conflicts/related‑party exposure
- No material related‑party transactions involving Garcia disclosed; Board considered independence after transaction review .
Executive sessions and oversight cadence
- Independent directors meet in executive session at each regular meeting; Audit Committee met 5x in 2024 and oversees financial reporting, compliance, cybersecurity, and AI risk .